Loading organizations...
§ Private Profile · Branford, CT, USA
Single-cell detection system for immune response assessment.
IsoPlexis has raised $193.8M across 5 funding rounds.
IsoPlexis has raised $193.8M in total across 5 funding rounds.
IsoPlexis has raised $193.8M across 5 funding rounds. Most recently, it raised $135.0M Debt / Series D in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 7, 2021 | $135M Debt Financing | SAM Chawla | Ally Bridge Group, BlackRock | Announced |
| Jan 9, 2020 | $20M Series C Plus | Sharon Kedar | — | Announced |
| May 14, 2019 | $25M Series C | Christopher Macgriff, PHD | Connecticut Innovations, Ironwood Capital, North Sound Capital | Announced |
| Sep 25, 2017 | $13.5M Series B | — | Connecticut Innovations, Ironwood Capital, North Sound Ventures | Announced |
| Aug 12, 2014 | $300K Venture Round | Matt Storeygard | — | Announced |
IsoPlexis has raised $193.8M in total across 5 funding rounds.
IsoPlexis's investors include Sam Chawla, Ally Bridge Group, BlackRock, Sharon Kedar, Christopher MacGriff, PhD, Connecticut Innovations, Ironwood Capital, North Sound Capital, North Sound Ventures, Matt Storeygard.